iShares Core MSCI EAFE ETF vs Centrus Energy Corp — how do they compare? iShares Core MSCI EAFE ETF trades at $96.21 (market cap $189.19B), while Centrus Energy Corp trades at $143.7 (market cap $2.91B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 65× Centrus Energy Corp's market cap, and iShares Core MSCI EAFE ETF is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 41 Days and Centrus Energy Corp for 29 Days on average.
| IEFA | LEU | |
|---|---|---|
Market Cap | $189.19B | $2.91B |
Volume | 8,441,787 | 903,777 |
Sector | Broad Market / Factor | Energy |
52-Week High | $101.41 | $436.00 |
52-Week Low | $85.06 | $138.18 |
Typical Hold Time | 41 Days | 29 Days |
Enterprise Value | — | $2.22B |
Signals from Pluang's Aura AI — not financial advice
IEFA (iShares Core MSCI EAFE ETF) trades at $96.20, down 1.08% with a bearish technical signal. The ETF manages $196 billion in assets, focusing on developed markets outside North America. Recent comparisons highlight its higher dividend yield versus competitors but lower recent performance than some peers. Technical indicators show oversold conditions with RSI at 28.63, while moving averages remain bearish with key support at $95.
The outlook remains cautious given bearish technical momentum and competitive pressure from lower-cost alternatives. International diversification benefits are offset by underperformance relative to global and emerging market ETFs. Key risks include currency fluctuations and concentrated U.S. market exposure driving defensive shifts.
Centrus Energy (LEU) trades at $147.14, down 4.38% on the day, amid neutral technical signals and mixed earnings performance. The stock shows elevated valuation ratios with a P/E of 75.18 and P/S of 6.68, while profitability metrics include a 10.23% net income margin and 8.05% ROE. Recent news highlights Centrus' strategic positioning as a key supplier of High-Assay Low-Enriched Uranium (HALEU) for advanced nuclear reactors, supported by new multi-year supply contracts with Antares and Radiant announced in September 2026.
The investment case balances strong growth potential in the nuclear fuel market against execution risks and high valuation. Analyst consensus suggests 46% buy ratings with a $218.10 price target, implying significant upside, but investors face risks from cash flow volatility, competitive pressures, and the company's reliance on successful capacity expansion. The recent $500 million stock offering provides capital for growth but may dilute existing shareholders.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →